
    
      Inclusion criteria were: cerebral palsy diagnosis, absence of other diseases that may impact
      gait performance, ambulatory for at least 20 meters, maximum level 2 according to Gross Motor
      Function Classification System. Exclusion criteria were: difficulty in following the
      instructions, severe lower extremity pain that affects mobility, orthopedic surgery within
      the last 12 months, Bothulium toxin A injection for lower extremity within the last 3 months
      and walking with a physical assistance from another person. Informed consents were obtained
      from the parents of the participants for the trial. Assessments were conducted in a special
      training and rehabilitation center where children with cerebral palsy received regular
      treatments.
    
  